Data scraping is a rapidly growing industry that involves the automated extraction of online data, often using AI tools, which raises significant privacy and intellectual property concerns. Partner Hayden Delaney and Research Clerk Jeremy Bazley from HopgoodGanim’s Intellectual Property, Technology and Cyber Security team discuss the response of governments and regulators as they introduce new laws to protect personal data and intellectual property: https://lnkd.in/geFuznem
5 Horizons Capital, LLC
商务咨询服务
Oklahoma City,OK 43 位关注者
Specializing in early stage clinical biotech investment & consulting
关于我们
We invest at the in-human clinical trial phase with select biotech partners. Our focus enables us to provide financing and consulting at a pivotal juncture, enabling sponsors to advance their therapies through rigorous testing, validation, and optimization. By aligning our strategy at this critical stage, we maximize the potential for breakthroughs that can provide significant benefits for both patients and shareholders.
- 网站
-
www.5horiz.com
5 Horizons Capital, LLC的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 2-10 人
- 总部
- Oklahoma City,OK
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Early Stage Biotech、Venture Investment & Consulting和CRO Partner
地点
-
主要
600 N Robinson Ave.
3
US,OK,Oklahoma City,73102
5 Horizons Capital, LLC员工
-
Brett Nelson
Director, IP Strategy & Implementation | Law | Lawyer | Intellectual Property | Technology | IP
-
Aaron Ray
Venture Investment & Consulting | Clinical Stage Biotech
-
William (Bill) Cronin
Venture Partner, Chief Executive Officer, Board Member
-
Kristie Buergler
Director of Business Development at 5 Horizons Capital, LLC
动态
-
Let's celebrate what we do best: partnerships. Join me at BIO-Europe, November 4–6, 2024, in Stockholm, Sweden, where the event marks 30 years of facilitating partnerships. Register here: https://lnkd.in/gZUZyMDZ Informa Connect
-
Heading home after an incredible #BIOEurope! Grateful for the inspiring conversations and connections made with both longtime friends and new partners. Looking forward to sharing more insights and takeaways soon. #OCT #DrugDiscovery #Biotech
-
Honored to represent Kadence Bio today at the Riyadh Global Medical Biotechnology Summit. It's inspiring to witness Saudi Arabia's ambitious Vision 2030 in action, particularly their strategic focus on advancing biotechnology and reproductive health solutions. Thank you to Dr Huda Alfardus, PhD, Executive MBA and organizing team for the invitation to share our journey in pioneering intimacy innovation and health of relationships. #Biotechnology #SaudiArabia #Vision2030 #Healthcare #Innovation #ReproductiveHealth #SexualHealth #BioInnovation #GlobalHealthcare #Startup
-
We are excited to announce that we are collaborating with Novotech as our clinical research organization (CRO) for the conduct of our first human efficacy clinical trial. Novotech is a global CRO headquartered in Australia, the selected location for our trial based on favourable R&D incentives and a streamlined regulatory process. Novotech has a strong network of sites with experience conducting studies in male sexual health. We look forward to working with the team there (including Chief Commercial Officer Barry Murphy) and advancing our mission to improve sexual and mental wellbeing through novel therapeutics! Through this relationship, we are also excited to be partnering with 5 Horizons Capital, LLC, an investment firm affiliated with Novotech to support the financing of clinical trials. 5 Horizons Capital’s involvement will facilitate the execution of this research through partial coverage of trial costs. Welcome to our new investors Aaron Ray and William (Bill) Cronin! Our CEO, John Boghossian, met with Aaron and Bill in London today. #CRO #Phase2 #clinicaltrials #Novotech #5HorizonsCapital